Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04407611 · ClinicalTrials.gov registry record · NA
Scalable Communication Modalities for Returning Genetic Research Results
A NA study of Lynch Syndrome and Hereditary Breast and Ovarian Cancer, sponsored by Boston University.
- Active
- Registry status
- NA
- Development phase
- 932
- Enrollment target
- 1
- Study location
NCT04407611 is a NA study of Lynch Syndrome and Hereditary Breast and Ovarian Cancer that is active but no longer recruiting, run by Boston University. The registered enrollment target is 932 participants, below the 2,272-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04407611, a NA study of Lynch Syndrome and Hereditary Breast and Ovarian Cancer, is active but no longer recruiting, sponsored by Boston University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 932 participants
- Enrollment target
- 1
- Study location
Study Summary
Efforts to examine the utility of alternate modalities for genetic results disclosure has widespread implications for how precision medicine research might yield direct health benefits for study participants. This study will examine the efficacy of an online self-guided program to return genetic results to a racial minority cohort population. Study results will provide empirical evidence on the effectiveness of alternate modalities for genetic results return, inform ongoing efforts to establish scalable approaches for effective return of genetic research results, and increase access to personal health information among African American women.
Conditions Studied
Interventions
- BEHAVIORAL Online modality
- BEHAVIORAL Genetic counselor follow-up
Study Locations (1)
Massachusetts
- BU School of Public Health, the research is being conducted remotely - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 932 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2026-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04407611
The ClinicalTrials.gov registry entry for NCT04407611 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 932 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,272-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (59% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lynch Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Online modality is the first listed.
NCT04407611 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04407611 about?
NCT04407611 is a clinical study titled "Scalable Communication Modalities for Returning Genetic Research Results". Efforts to examine the utility of alternate modalities for genetic results disclosure has widespread implications for how precision medicine research might yield direct health benefits for study participants. This study will examine the efficacy of an online self-guided program to return genetic res...
What is the current status of trial NCT04407611?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 932 participants. The study started on 2023-03-06. Estimated completion is 2026-03.
What conditions does trial NCT04407611 study?
This clinical trial studies the following conditions: Lynch Syndrome, Hereditary Breast and Ovarian Cancer.
What interventions are being tested in trial NCT04407611?
The interventions under investigation include: Online modality (BEHAVIORAL), Genetic counselor follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT04407611?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04407611 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lynch Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identifying and Caring for Individuals With Inherited Cancer Syndrome
RECRUITING · NA
-
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
RECRUITING · NA
-
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
RECRUITING · NA
-
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
ACTIVE NOT RECRUITING · NA
-
Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families
ACTIVE NOT RECRUITING · NA
-
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Lynch Syndrome
All registered trials for this condition
Hereditary Breast and Ovarian Cancer
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.